What liabilities do multistate telemedicine corporations face when prescribing controlled substances for adult ADHD compliance across three different jurisdictions?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What liabilities do multistate telemedicine corporations face when prescribing controlled substances for adult ADHD compliance across three different jurisdictions?
3 real searches · 1 real-search pass
2026 federal DEA telemedicine controlled substances prescribing extension Ryan Haight Act rules official DEA October 2026Google ↗
OBSERVED
state medical board telemedicine prescribing controlled substances ADHD corporate practice medicine multistate compliance official guidanceGoogle ↗
OBSERVED
DEA controlled substance practitioner registration state location telemedicine prescribing patient state registrationGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
2026 federal DEA telemedicine controlled substances prescribing extension Ryan Haight Act rules official DEA October 2026 Google ↗
state medical board telemedicine prescribing controlled substances ADHD corporate practice medicine multistate compliance official guidance Google ↗
DEA controlled substance practitioner registration state location telemedicine prescribing patient state registration Google ↗
- HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026 · hhs.gov
- 90 FR 61301 - Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications - Content Details · govinfo.gov
- 21 CFR § 1307.41 - Temporary extension of certain COVID-19 telemedicine flexibilities for prescription of controlled medications. | Electronic Code of Federal Regulations (e-CFR) | US Law · law.cornell.edu
- Drug Enforcement Administration · deadiversion.usdoj.gov
- Diversion Control Division · deaecom.gov
- Guidance Documents · apps.deadiversion.usdoj.gov
- Federal Register, Volume 90 Issue 247 (Wednesday, December 31, 2025) · govinfo.gov
- 5.1.4: Telemedicine · ncmedboard.org
- Telemedicine FAQs | Department of State · pa.gov
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2026 federal DEA telemedicine controlled substances prescribing extension Ryan Haight Act rules official DEA October 2026 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
state medical board telemedicine prescribing controlled substances ADHD corporate practice medicine multistate compliance official guidance OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
DEA controlled substance practitioner registration state location telemedicine prescribing patient state registration OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |